Although immunolabelling of fully glycosylated αDG with VIA4–1 was reduced in dystrophinopathy patients, no significant relationship between reduction of LARGE expression and αDG hypoglycosylation was detected. The gene discussed is LARGE1; the disease is neuromuscular disease caused by qualitative or quantitative defects of dystrophin.